Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ư¡Àû ÀÓ»ó ¾ç»ó ¹× ¿¹Èĸ¦ °¡Áö´Â °áÀå ¹× Á÷ÀåÀÇ Á¡¾×¼º ¼±¾Ï Characteristic Clinical Behaviors of and Prognosis for Mucinous Adenocarcinomas in the Colon and Rectum

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2003³â 19±Ç 6È£ p.379 ~ 385
À¯À±½Ä, ±èÈñö, ¹Ú»óÁØ, À¯ÀåÇÐ, ±èÁ¤¼±, ÀÌ°­È«, À¯Ã¢½Ä, ±èÁøõ,
¼Ò¼Ó »ó¼¼Á¤º¸
À¯À±½Ä ( Yoo Yuen-Sik ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

±èÈñö ( Kim Hee-Cheol ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹Ú»óÁØ ( Park Sang-Jun ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
À¯ÀåÇР( Yoo Jang-Hak ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èÁ¤¼± ( Kim Jung-Sun ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÌ°­È« ( Lee Kang-Hong ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
À¯Ã¢½Ä ( Yu Chang-Sik ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èÁøõ ( Kim Jin-Cheon ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose: The clinical significance of a mucinous-type colorectal adenocarcinoma is still controversial. Mucinous colorectal adenocarcinomas have been suggested to have distinct clinicopathologic features, i.e., early-onset, right-side dominancy, and poor prognosis. We aimed to verify the biological behaviors of and survivals for mucinous adenocarcinomas compared with non-mucinous adenocarcinomas.

Methods: Using a database of colorectal cancers at Asan Medical Center between 1989 and 2000, we enrolled 121 mucinous adenocarcinoma and 2,289 non-mucinous adenocarcinoma patients in this study. Clinical, pathological characteristics of and prognoses for mucinous adenocarcinomas were analyzed and compared with those for non-mucinous adenocarcinomas, retrospectively. The median follow-up period was 24 (0¢¦113) months for mucinous adenocarcinomas and 32 (0¢¦130) months for non-mucinous adenocarcinoma.

Results: Compared to non-mucinous adenocarcinomas, mucinous adenocarcinomas showed distinctive clinicopathologic features of early-onset (P£¼0.001), frequent family history (P£¼0.001), right-side dominancy (P=0.010), advanced stage at diagnosis (P£¼0.001), and common peritoneal seeding at diagnosis (P£¼0.001). The recurrence rate in the mucinous adenocarcinoma group was 45.2% during the follow-up period: 21.6% distant metastasis, 14.3% peritoneal dissemination, 5.7% local recurrence, and 3.6% simultaneous local recurrence and distant metastasis. The five-year survival rates in stages II and III were 70% and 48.7%, respectively, for mucinous adenocarcinomas and 92% and 50.2%, respectively, for non-mucinous adenocarcinomas. This difference was statistically significant.

Conclusions: Mucinous adenocarcinomas seem to have distinct biologic behaviors with different clinicopathologic features and poor prognosis. A surgical approach with a follow-up schedule considering the characteristics of mucinous adenocarcinomas is needed. J Korean Soc Coloproctol 2003;19:379-385

Å°¿öµå

°áÀåÁ÷ÀåÁ¾¾ç; Á¡¾×¼º ¼±¾Ï;¿¹ÈÄ;»ýÁ¸À²
Colorectal neoplasms;Adenocarcinoma Mucinous;Prognosis;Survival rate

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS